Expert Review of Anti-Infective Therapy

Article	Citations
Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition	184
Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence	82
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	63
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis	60
Genetic heterogeneity of group A rotaviruses: a review of the evolutionary dynamics and implication on vaccination	59
Impact of the COVID-19 pandemic on the utilisation and quality of antibiotic use in the Scottish primary care setting: a population-based segmented interrupted time-series analysis	58
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	57
Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits	56
Recurrent bloodstream infections after allogeneic hematopoietic cell transplantation	49
Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials	46
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review	40
The antifungal pipeline for invasive fungal diseases: what does the future hold?	39
Overcoming clinical challenges in the management of invasive fungal infections in low- and middle-income countries (LMIC)	39
Is the world crippled by antimicrobial resistance, or simply lacking information?	38
Analysis of clinical characteristics and prognostic factors of ARDS caused by community-acquired pneumonia in people with different immune status	38
Hospital-acquired bacterial pneumonia in critically ill patients: from research to clinical practice	36
Can we use azithromycin eye drops for gonococcal ophthalmia prophylaxis in the United States?	36
Computational analysis of target genes in monkeypox virus infection and potential therapeutic precursors	35
Host-directed therapies for malaria and tuberculosis: common infection strategies and repurposed drugs	34
The clinical application of traditional Chinese medicine NRICM101 in hospitalized patients with COVID-19	32
Real-life experience of treating HCV co-infection among HIV-infected population in Egypt: single-center experience	31
How can we tackle the overuse of antibiotics in low- and middle-income countries?	31
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae	31
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects	28
Neonatal ocular prophylaxis in the United States: is it still necessary?	28

Identification of antibiotic consumption targets for the management of Clostridioides difficile infection in hospitals- a threshold logistic modelling approach	27
Health literacy, knowledge, household disposal, and misuse practices of antibiotics among UAE residents: a nationwide cross-sectional study	27
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections	27
Part 2: Understanding the role of Malassezia spp. in skin disorders: pathogenesis of Malassezia associated skin infections	26
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials	26
Visceral leishmaniasis elimination in India: progress and the road ahead	25
Updates in the management of respiratory virus infections in ICU patients: revisiting the non-SARS-CoV-2 pathogens	22
Mitigation of insufficient hospital workforce and personal protective equipment in the anti-COVID-19 campaign in mainland China	21
Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age	20
Monoclonal antibodies for the treatment of COVID-19 infection in children	20
Molecular detections of coronavirus: current and emerging methodologies	19
Building upon the core elements of antifungal stewardship: practical recommendations for effective antifungal stewardship in resource-limited settings	19
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas	18
Biosimilars as antivirals: opportunities and challenges	17
New advances in the treatments of drug-resistant tuberculosis	17
Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease	17
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	16
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?	16
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	16
Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole onAchromobacter, Burkholderia, andStenotrophomonasisolates	15
Strategies to improve the diagnosis and clinical treatment of dermatophyte infections	15
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	15
Wide-spectrum antibiotic prophylaxis guarantees optimal outcomes in drowned donor kidney transplantation	15
Identification of active compounds of traditional chinese medicine derived from maxing shigan decoction for COVID-19 treatment: a meta-analysis and in silico study	15
Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy	14
Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses	14
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations	14
Drug recommendation for optimization on treatment outcome for MDR/RR-TB based on a multi-center, large scale, retrospective cohort study in China	14
Understanding the genetic basis of immune responses to fungal infection	14
Comparing prolonged infusion to intermittent infusion strategies for beta-lactam antibiotics in patients with gram-negative bacterial infections: a systematic review and meta-analysis	13
Overcoming challenges in the management of recurrent urinary tract infections	13
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection	13
Emerging and alternative strategies for the treatment of nontuberculous mycobacterial infections	13
Clostridioides difficile infection in inflammatory bowel disease: a clinical review	13
Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better	12
Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy	12
Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs	12
Therapeutic strategies to address monkeypox	12
Improving management of febrile neutropenia in oncology patients: the role of artificial intelligence and machine learning	12
Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas	12
Therapeutic drug monitoring (TDM) in real-time: a need for the present future	12
Alternative drugs for the treatment of gonococcal infections: old and new	11
Prevalence and determinants of self-medication with antibiotics among general population in Afghanistan	11
Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge	11
Evaluating diagnostic tools, outcome measures and antibiotic approach in diabetic foot osteomyelitis: a scoping review and narrative synthesis	11
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	11
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	11
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study	11
Potential activity of nanomaterials to combat SARS-CoV-2 and mucormycosis ‎coinfection‎	11
Bacterial co-infections, secondary infections and antimicrobial use among hospitalized COVID-19 patients in the sixth wave in Pakistan: findings and implications	11

Comparative efficacy and safety of antiviral traditional Chinese medicine injections for viral pneumonia: a systematic review and network meta-analysis	10
Androgen receptor, a possible anti-infective therapy target and a potent immune respondent in SARS-CoV-2 spike binding: a computational approach	10
Effective antimicrobial therapies needed for treatment of severe infections in African newborns	10
Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin	10
Efficacy and acceptability of different anti-fungal interventions in oropharyngeal or esophageal candidiasis in HIV co-infected adults: a pilot network meta-analysis	10
New insights into the treatment of acute otitis media	10
Cross-testing of direct-action antivirals, universal vaccines, or search for host-level antivirals: what will sooner lead to a generic capability to combat the emerging viral pandemics?	10
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision	10
Clinical efficacy and safety of novel lipoglycopeptides in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials	9
How do we best manage Clostridioides difficle infections in the elderly?	9
Langya henipavirus outbreak	9
Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship	9
Evaluation of Namibia’s antiretroviral therapy guidelines’ recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study	9
What is the impact of SARS-CoV-2 infection during pregnancy on child immunity?	9
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America	9
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	8
Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability	8
System for administering and monitoring hydroxychloroquine prophylaxis for COVID-19 in accordance with a national advisory: preliminary experience of a tertiary care institute in India	8
The circadian rhythm of viruses and its implications on susceptibility to infection	8
Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain	8
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	8
Effect of adalimumab interventions on general infection among adults: a systematic review and meta-analysis of randomized controlled trials	8
From Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Perspectives in Pediatric Patients with Chronic Hepatitis B	8
Evaluation of truenat assays for the diagnosis of pulmonary and extrapulmonary tuberculosis: a systematic review and meta-analysis	8
Potentially effective antimicrobial treatment for pneumonia caused by isolates of carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii complex spe	8
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents	8
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers	8
The impacts of the national centralized drug procurement policy on the use of policy-related antibiotic agents: the case of Shaanxi province, China	7
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	7
How do we change our approach to COVID with the changing face of disease?	7
Now that griseofulvin is not available, what to do with tinea capitis treatments?	7
The rise of mucormycosis in Covid-19 patients in India	7
An assessment of the index of rational drug prescribing for severe acute respiratory infections among hospitalised children in Northern Nigeria: a retrospective study	7
Outpatient treatment options to address the SARS-CoV-2 variant Omicron	7
Impact of some antiviral drugs on health care utilization for patients with COVID-19: a systematic review and meta-analysis	7
Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)	7
Gram-negative blood stream infections: prospects and challenges of rapid antimicrobial susceptibility testing	7
Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients	7
Waking up to the Naegleria threat: urgent measures needed to protect public health in Pakistan	7
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis	7
Surveillance and prevention of healthcare-associated infections: best practices to prevent ventilator-associated events	7
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	7
Meropenem-vaborbactam: a critical positioning for the management of infections by Carbapenem-resistant Enterobacteriaceae	7
Vitamin D receptor gene polymorphism and vitamin D supplementation on clinical/ treatment outcome in tuberculosis: current and future perspectives	7
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	6
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals	6
Effects of supplementation with low-dose group B vitamins on clinical and biochemical parameters in critically ill patients with COVID-19: a randomized clinical trial	6
Use of adjuvants to improve antibiotic efficacy and reduce the burden of antimicrobial resistance	6
Reviewing novel treatment options for carbapenem-resistant Enterobacterales	6
Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)	6
Can the immunological system of the upper respiratory tract, improved by physical exercise, act as a first immunological barrier against SARS-CoV-2?	6
Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations	6
A profile of the live biotherapeutic product RBX2660 and its role in preventing recurrent Clostridioides difficile infection	6
Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice	6
Phage therapy in pediatrics: the way forward for difficult-to-treat infections?	6
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	6
Febrile neutropenia management in high-risk neutropenic patients: a Narrative Review on Antibiotic Prophylaxis and empirical treatment	6
Evaluation of favipiravir in the treatment of COVID-19 based on the real-world	6
The potential of 4D’s approach in curbing antimicrobial resistance among bacterial pathogens	6
Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies	6
Could the next disease X be pandemic of virus-induced encephalitis? what should be our first medical response?	6
Escalation of antimicrobial resistance among MRSA part 2: focus on infections and treatment	6
Discovery of novel antischistosomal scaffolds from the open access Pandemic Response Box	6
Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities	6
Lactic acid bacteria: prominent player in the fight against human pathogens	6
Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?	6
Is it time to reconsider prophylactic antimicrobial use for hematopoietic stem cell transplantation? a narrative review of antimicrobials in stem cell transplantation	6
Practical diagnostic algorithms for Chagas disease: a focus on low resource settings	6
Analysis of antimicrobial drug usage in psychiatric specialized hospitals during the pandemic in China	6
The effects of the pandemic in cases of heart failure	5
Brain-eating amoebae: is killing the parasite our only option to prevent death?	5
Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy	5
Novel treatment dynamics for biofilm-related infections	5
Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria	5
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials	5
Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications	5
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges	5
IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients	5
Gram-positive infections in special populations. Expert view on the role of dalbavancin	5
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review	5

Mistakes to avoid in the management of abdominal tuberculosis	5
Associations of infection control measures and norovirus outbreak outcomes in healthcare settings: a systematic review and meta-analysis	5
Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice	5
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China	5
Efficacy and appropriateness of novel antibiotics in response to antimicrobial-resistant gram-negative bacteria in patients with sepsis in the ICU	5
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19	5
Tocilizumab for the treatment of COVID-19	5
Single ascending dose safety, tolerability, and pharmacokinetic study of econazole in healthy volunteers	5
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’	5
Mortality associated with third generation cephalosporin-resistance in Enterobacteriaceae infections: a multicenter cohort study in Southern China	5
Understanding Staphylococcus aureus internalisation and induction of antimicrobial tolerance	5
The clinical outcomes and effectiveness of antiviral agents among underweight patients with COVID-19	5
Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators	4
Applications of β-defensins against infectious pathogenic microorganisms	4
Classification for β-lactamases: historical perspectives	4
Prevention and treatment of burn wound infections: the role of topical antimicrobials	4
Ethical challenges of prospective clinical trials during the COVID-19 pandemic	4
Clostridioides difficile infection: an emerging zoonosis?	4
Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?	4
Bismuth add-on improves the efficacy of 2-week tegoprazan-based triple therapy for first-line Helicobacter pylori eradication: a real-world evidence study	4
Practical use of fecal microbiota spores, live-brpk (formerly SER-109): an oral therapeutic for the prevention of recurrent Clostridioides difficile infection	4
Treatment of vaginitis caused by non-albicans Candida species	4
Candida auris biofilm: a review on model to mechanism conservation	4
Prevalence of antibiotic resistance in clinical isolates of Mycobacterium kansasii : a systematic review and meta-analysis	4
Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective	4
Anti-MRSA quinolones for acute bacterial skin and skin structure infection: a systematic review and meta-analysis of randomized controlled trials	4
Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China	4
The rationale for including osteopathic manipulative treatment in the management of infections: a hermeneutic review	4
Real-world implementation of dolutegravir plus lamivudine in people living with HIV in Southwest China	4
Clinical efficacy and safety of ceftobiprole in the treatment of acute bacterial skin and skin structure infection: a systematic review and meta-analysis of randomized controlled trials	4
Phenotypic, genotypic, and metabolic resistance mechanisms of ESKAPE bacteria to chemical disinfectants: a systematic review and meta-analysis	4
Efficacy and safety of the all-oral bedaquiline-containing regimen as treatment for pediatric multidrug/rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study	4
Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: an observational prospective open label user survey	3
Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials	3
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	3
Management of calcified cysticerci in the brain parenchyma: treating the dead parasite	3
Artificial intelligence and prescription of antibiotic therapy: present and future	3
Ampicillin-resistant and vancomycin-susceptible Enterococcus faecium bacteremia: a clinical narrative review	3
Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19	3
Mycosynthesis of AgNPs: mechanisms of nanoparticle formation and antimicrobial activities	3
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials	3
Statement of Retraction: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial	3
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis	3
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients	3
Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications	3
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies	3
SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis	3
Dengue vaccine: an update	3
Treatment of carbapenem-resistantPseudomonas aeruginosainfections: a case for cefiderocol	3
Suppressive antibiotic treatment (SAT) in the era of MDRO infections: a narrative review	3
Scrub typhus and antibiotic-resistant Orientia tsutsugamushi	3
Mechanisms of resistance to cell wall and plasma membrane targeting antifungal drugs in Candida species isolated in Africa	3
Reemergence of monkeypox: prevention and management	3
Escalation of antimicrobial resistance among MRSA part 1: focus on global spread	3
Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant t	3
Clinical effectiveness of oral antivirals for non-hospitalized adult COVID-19 patients aged 18–60 years	3
Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies	3
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies	3
Diagnostic stewardship based on patient profiles: differential approaches in acute versus chronic infectious syndromes	3
Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review	3
Treating urinary tract infections in the era of antibiotic resistance	3
Drug Inspector as an antibiotic steward: challenges and recommendations to implement national action plan of Pakistan on antimicrobial resistance	3
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis	3